Psychological Experience of Smoking Addiction in Family and Friends of Schizophrenic Adults Who Smoke Daily: A Qualitative Study.
e-cigarette
qualitative research
schizophrenia
smoking addiction
thematic analysis
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
22 Feb 2023
22 Feb 2023
Historique:
received:
15
01
2023
revised:
13
02
2023
accepted:
20
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
The smoking addiction of patients with severe mental disorders has consequences not only for the patients but also for the people around them. This is qualitative research on family and friends of patients with Schizophrenia spectrum disorders to investigate their perception and vision of smoking, its impact on the patients' physical and mental health, and the possible attempts to combat addiction. The research also investigates the participants' views on electronic cigarettes as a means of replacing traditional cigarettes and helping the patient to quit smoking. The survey method used was a semi-structured interview. The answers were recorded, transcribed and analyzed with the technique of thematic analysis. The results of this study show that the view of most participants on smoking is negative (83.3%), although not all of them consider smoking cessation treatments for these patients of primary importance (33.3%). Nevertheless, a good number of them have tried to intervene spontaneously with their own resources and strategies (66.6%). Finally, low-risk products, and in particular electronic cigarettes, are considered by many participants as a useful alternative to traditional cigarettes in patients with schizophrenia spectrum disorders. About the meaning that cigarettes can assume for the patient, recurring themes emerge: they are considered as a way to manage nervousness and tension or as a means to contrast daily monotony and boredom or repeat usual gestures and habits.
Identifiants
pubmed: 36900649
pii: healthcare11050644
doi: 10.3390/healthcare11050644
pmc: PMC10000785
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur Arch Psychiatry Clin Neurosci. 2002 Apr;252(2):86-92
pubmed: 12111342
J Psychiatr Res. 2014 Jan;48(1):102-10
pubmed: 24139811
Int J Environ Res Public Health. 2015 Mar 24;12(4):3428-38
pubmed: 25811767
Nature. 2014 Feb 13;506(7487):185-90
pubmed: 24463508
J Dual Diagn. 2013;9(1):87-93
pubmed: 23750123
Cochrane Database Syst Rev. 2020 Oct 14;10:CD010216
pubmed: 33052602
JAMA Netw Open. 2019 Mar 1;2(3):e191047
pubmed: 30924893
Am J Addict. 2007 Mar-Apr;16(2):101-10
pubmed: 17453611
Int J Environ Res Public Health. 2013 Jan 28;10(2):446-61
pubmed: 23358230
J Child Psychol Psychiatry. 2019 Jul;60(7):793-802
pubmed: 30908641
Acta Neuropsychiatr. 2009 Jun;21(3):109-20
pubmed: 26953749
PLoS One. 2018 Aug 23;13(8):e0202028
pubmed: 30138449
Int J Environ Res Public Health. 2021 Jul 15;18(14):
pubmed: 34299972
Eur Addict Res. 2016;22(4):215-32
pubmed: 27161506
Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
Tob Control. 2014 Nov;23(e2):e147-53
pubmed: 24727731
Int J Drug Policy. 2015 Jun;26(6):595-600
pubmed: 25687714
Int J Environ Res Public Health. 2017 Mar 31;14(4):
pubmed: 28362360
Ther Adv Drug Saf. 2014 Apr;5(2):67-86
pubmed: 25083263
Schizophr Res. 2018 Apr;194:86-90
pubmed: 28285025
Tob Control. 2019 Jan;28(1):95-100
pubmed: 29563220
J Exp Soc Psychol. 2009 Feb 1;45(2):313
pubmed: 20126293
BMC Psychol. 2020 Apr 16;8(1):33
pubmed: 32299500
Addiction. 2016 Nov;111(11):2032-2040
pubmed: 27338716
Int J Environ Res Public Health. 2013 Oct 28;10(11):5507-22
pubmed: 24169412
Pharmacol Biochem Behav. 2007 Feb;86(2):263-83
pubmed: 17116324
Pneumonia (Nathan). 2016 Apr 12;8:4
pubmed: 28702284
Healthcare (Basel). 2022 Nov 13;10(11):
pubmed: 36421599
BMC Public Health. 2011 Oct 11;11:786
pubmed: 21989407
Schizophr Res. 2016 Feb;170(2-3):290-300
pubmed: 26794596
Int J Environ Res Public Health. 2021 Dec 07;18(24):
pubmed: 34948485